Articular cartilage degeneration in osteoarthritis is a major cause of disability affecting more than 43 million lives in the US. Damaged cartilage does not heal. Cartilage tissue engineering based on mesenchymal stem cell (MSC) technology offers the promise of manufacturable autologous tissue replacements of arbitrary size and shape, using cells from a bone marrow biopsy. This Bioengineering Research Grant proposal is driven by the need for cartilage tissue engineering to make the transition to a reproducible clinical therapy. To accomplish this, the processes involved must be thoroughly understood, and standardized protocols must be established. The global hypothesis underlying this proposal is that by exposing the cell scaffold constructs in a controlled, in vitro environment to conditions that favor chondrogenic differentiation, these constructs will develop the specific properties required for survival after implantation in the joint. Two major problems must be solved before tissue engineering can become a routine treatment for cartilage defects: transport of nutrients and waste products to and from the cells within the construct, and mechanical conditioning of the constructs to allow function in situ. We propose five Specific Aims, which address specific issues related to mass transport and mechanical conditioning, and their impact on construct functionality in vivo. These are:
Specific Aim 1 : To assess the mass transfer problem in cartilage tissue engineering. This will lead to better understanding of mass transfer within the constructs and will serve to evaluate the counter-measures proposed to improve mass transfer.
Specific Aim 2 : To develop a cartilage bioreactor monitoring and process control system. We will implement this technology to identify and characterize process control parameters in cartilage tissue engineering systems.
Specific Aim 3 : To develop countermeasures to specific mass transport limitations. In this Specific Aim, we will examine strategies to improve mass transfer in the constructs.
Specific Aim 4 : To implement and assess mechanical stimulation of the composites, using a system in which controlled, physiologically relevant loads can be applied, and identifying loading parameters that improve the mechanical properties of the construct.
Specific Aim 5 : To evaluate the composite constructs in vivo, as survival and integration of the manufactured construct in the joint defines the success of the tissue engineering process. The practical value of the proposed research is in the new insights it will provide into the technical issues surrounding cartilage tissue engineering and cartilage repair, and into the complex biology of the joint. If successful, these studies will provide novel principles and guidelines for the successful management of articular cartilage injuries.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR050208-03
Application #
7213456
Study Section
Special Emphasis Panel (ZRG1-MOSS-G (01))
Program Officer
Wang, Fei
Project Start
2005-04-05
Project End
2010-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
3
Fiscal Year
2007
Total Cost
$319,158
Indirect Cost
Name
Case Western Reserve University
Department
Orthopedics
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Chung, Chen-Yuan; Heebner, Joseph; Baskaran, Harihara et al. (2015) Ultrasound Elastography for Estimation of Regional Strain of Multilayered Hydrogels and Tissue-Engineered Cartilage. Ann Biomed Eng 43:2991-3003
Mansour, Joseph M; Gu, Di-Win Marine; Chung, Chen-Yuan et al. (2014) Towards the feasibility of using ultrasound to determine mechanical properties of tissues in a bioreactor. Ann Biomed Eng 42:2190-202
Shao, Yvonne Y; Wang, Lai; Welter, Jean F et al. (2012) Primary cilia modulate Ihh signal transduction in response to hydrostatic loading of growth plate chondrocytes. Bone 50:79-84
Solchaga, Luis A; Penick, Kitsie J; Welter, Jean F (2011) Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol 698:253-78
Auletta, Jeffery J; Zale, Elizabeth A; Welter, Jean F et al. (2011) Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential. Stem Cells Int 2011:235176
Walker, Jason M; Myers, Ashley M; Schluchter, Mark D et al. (2011) Nondestructive evaluation of hydrogel mechanical properties using ultrasound. Ann Biomed Eng 39:2521-30
Sarkar, Saheli; Bustard, Bethany L; Welter, Jean F et al. (2011) Combined experimental and mathematical approach for development of microfabrication-based cancer migration assay. Ann Biomed Eng 39:2346-59
Abrahamsson, Christoffer K; Yang, Fan; Park, Hyoungshin et al. (2010) Chondrogenesis and mineralization during in vitro culture of human mesenchymal stem cells on three-dimensional woven scaffolds. Tissue Eng Part A 16:3709-18
Liang, Wan-Hsiang; Kienitz, Brian L; Penick, Kitsie J et al. (2010) Concentrated collagen-chondroitin sulfate scaffolds for tissue engineering applications. J Biomed Mater Res A 94:1050-60
Solchaga, Luis A; Penick, Kitsie; Goldberg, Victor M et al. (2010) Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A 16:1009-19

Showing the most recent 10 out of 14 publications